V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210032715 | 210008897 | 1.64 | 63.7 | Not known (9) | 2014-12-15 | 2015-03-16 | UKALL14- Cons Cycle 2 | N | N | 210016850 | UKALL2014 |
| 210032716 | 210019620 | 1.85 | 63 | Palliative (P) | null | 2016-04-14 | UKALL14- Cons Cycle 3 | Y | null | 210016857 | UKALL2014 |
| 210032717 | 210008905 | 1.75 | 88 | Curative (C) | 2015-12-12 | 2015-12-25 | UKALL14- Maintenance | Y | Y | 210016869 | UKALL2014 |
| 210032718 | 210008906 | 1.78 | 108 | Curative (C) | 2015-02-01 | 2015-10-02 | UKALL14- Intens/CNS Proph | Y | N | 210016869 | UKALL2014 |
| 210032719 | 210008908 | 1.83 | 98.7 | Curative (C) | 2015-07-08 | 2015-07-18 | UKALL14- Ph 2 Induction | Y | N | 210016886 | UKALL2014 |
| 210032720 | 210008913 | 1.77 | 94.2 | Curative (C) | null | 2016-06-03 | UKALL14- Maintenance | 1 | null | 210016897 | UKALL2014 |
| 210032721 | 210008914 | 1.83 | 60.7 | Palliative (P) | null | 2014-11-15 | UKALL14- Maintenance | N | null | 210016914 | UKALL2014 |
| 210032722 | 210008917 | 1.68 | 84.8 | Disease modification (D) | 2015-10-07 | 2015-10-07 | UKALL14- Maintenance | N | null | 210016920 | UKALL2014 |
| 210032723 | 210008918 | 0 | 57.2 | Curative (C) | 2013-12-11 | 2014-07-22 | UKALL14- FMC (1 day) Conditioning | 02 | N | 210016930 | UKALL2014 |
| 210032724 | 210008920 | 0 | 87.3 | Disease modification (D) | 2017-08-12 | 2018-01-11 | UKALL 14 TRIAL | Y | N | 210016939 | UKALL2014 |
| 210032725 | 210008926 | 1.82 | 91.2 | Curative (C) | 2017-03-03 | 2017-03-04 | UKALL14- Ph 1 Induction | N | N | 210016943 | UKALL2014 |
| 210032726 | 210008928 | 1.72 | 86.8 | null | 2012-07-23 | 2014-06-18 | UKALL14- Maintenance | 1 | N | 210016965 | UKALL2014 |
| 210032727 | 210026519 | 1.63 | 106 | Curative (C) | null | 2016-03-03 | UKALL14- Maintenance | Y | N | 210016982 | UKALL2014 |
| 210032728 | 210008932 | 1.68 | 74.2 | Curative (C) | null | 2017-10-11 | UKALL14- Cons Cycle 2 | N | N | 210016984 | UKALL2014 |
| 210032729 | 210008934 | 1.76 | null | Curative (C) | 2015-03-23 | 2015-07-31 | UKALL14- Maintenance | 01 | N | 210016990 | UKALL2014 |
| 210032731 | 210008939 | 1.82 | 69.5 | Not known (9) | 2015-04-13 | 2015-04-18 | UKALL14- FMC (1 day) Conditioning | 1 | N | 210017000 | UKALL2014 |
| 210032732 | 210008941 | 1.85 | 90 | Curative (C) | 2015-01-19 | 2017-10-31 | UKALL 14 TRIAL | Y | N | 210017005 | UKALL2014 |
| 210032733 | 210036026 | 1.71 | 94.2 | Curative (C) | null | 2013-08-29 | UKALL14- FMC (2 day) Conditioning | Y | null | 210017006 | UKALL2014 |
| 210032734 | 210008944 | 1.68 | 79.4 | Curative (C) | 2014-06-01 | 2014-06-03 | UKALL14- Intens/CNS Proph | 01 | null | 210017034 | UKALL2014 |
| 210032735 | 210008947 | 1.76 | 83.8 | Curative (C) | 2014-07-15 | 2014-10-26 | UKALL14- Ph 2 Induction | 02 | null | 210017038 | UKALL2014 |
| 210032736 | 210008949 | 1.83 | 86.9 | Disease modification (D) | 2014-12-11 | 2015-01-14 | UKALL14- Ph 2 Induction + Imatinib | Y | N | 210017042 | UKALL2014 |
| 210032737 | 210008951 | 1.81 | 77.8 | Curative (C) | 2014-04-25 | 2014-08-14 | UKALL14- Ph 2 Induction | 01 | N | 210017044 | UKALL2014 |
| 210032738 | 210026534 | 1.82 | null | Curative (C) | 2013-12-29 | 2014-03-30 | UKALL14- Maintenance | Y | null | 210017053 | UKALL2014 |
| 210032739 | 210008955 | 1.75 | 78.6 | Curative (C) | 2016-07-21 | 2016-07-24 | UKALL14- Maintenance | 01 | N | 210017066 | UKALL2014 |
| 210032740 | 210026537 | 1.76 | 78 | Curative (C) | 2016-04-18 | 2016-04-24 | UKALL14- Ph 2 Induction + Imatinib | Y | Y | 210017071 | UKALL2014 |
| 210032741 | 210026538 | null | 50 | Neo-adjuvant (N) | 2016-09-11 | 2017-02-06 | UKALL14- Maintenance | Y | N | 210017073 | UKALL2014 |
| 210032742 | 210030659 | 1.76 | null | Curative (C) | 2013-12-07 | 2014-03-29 | UKALL 14 TRIAL | 01 | N | 210017081 | UKALL2014 |
| 210032743 | 210008962 | 1.88 | 77.5 | Unknown (U) | 2013-08-06 | 2013-12-26 | UKALL14- Intens/CNS Proph | 01 | N | 210017102 | UKALL2014 |
| 210032744 | 210008965 | 1.87 | 60.5 | Curative (C) | 2014-01-19 | 2014-06-21 | UKALL14- Cons Cycle 2 | 02 | N | 210017106 | UKALL2014 |
| 210032745 | 210030661 | 1.46 | 86.9 | Curative (C) | 2016-09-09 | 2016-10-16 | UKALL14- Maintenance | Y | N | 210017119 | UKALL2014 |
| 210032746 | 210008972 | 1.75 | 61.7 | Curative (C) | 2018-06-27 | 2018-07-01 | UKALL14- Intens/CNS Proph | 01 | N | 210017129 | UKALL2014 |
| 210032747 | 210030665 | 1.85 | 70 | Curative (C) | 2018-05-19 | 2018-06-01 | UKALL14- Cons Cycle 2 | N | Y | 210017141 | UKALL2014 |
| 210032748 | 210008978 | 1.76 | 120 | Palliative (P) | 2015-12-30 | 2015-12-30 | UKALL 14 TRIAL | 02 | N | 210017152 | UKALL2014 |
| 210032749 | 210008984 | 1.9 | 84 | Palliative (P) | 2015-12-31 | 2016-03-21 | UKALL14- Maintenance | Y | N | 210017169 | UKALL2014 |
| 210032750 | 210008987 | 1.66 | 75.5 | Curative (C) | 2015-04-10 | 2015-04-10 | UKALL14- Maintenance | 1 | N | 210017172 | UKALL2014 |
| 210032751 | 210008989 | 1.75 | null | Curative (C) | 2014-06-26 | 2014-06-27 | UKALL14- Maintenance | N | N | 210017183 | UKALL2014 |
| 210032752 | 210030670 | 1.76 | 94.499 | Curative (C) | null | 2018-04-24 | UKALL14- Intens/CNS Proph | N | N | 210017197 | UKALL2014 |
| 210032753 | 210008992 | 1.94 | 61 | Curative (C) | 2015-01-10 | 2015-01-10 | UKALL14- Intens/CNS Proph | 2 | null | 210017201 | UKALL2014 |
| 210032754 | 210019681 | 0 | 67 | Curative (C) | 2017-10-22 | 2017-10-22 | UKALL14- Intens/CNS Proph | Y | N | 210017207 | UKALL2014 |
| 210032755 | 210008996 | 1.65 | 81 | Curative (C) | null | 2013-04-18 | UKALL14- Maintenance | Y | N | 210017210 | UKALL2014 |
| 210032756 | 210008999 | 1.89 | 100 | Disease modification (D) | 2014-05-14 | 2014-06-17 | UKALL14- Cons Cycle 1 | 2 | null | 210017238 | UKALL2014 |
| 210032757 | 210009003 | null | 73.1 | Curative (C) | 2015-10-07 | 2015-10-13 | UKALL14- Cons Cycle 3 | 1 | null | 210017255 | UKALL2014 |
| 210032758 | 210033247 | 1.78 | 67 | Curative (C) | 2017-04-27 | 2017-08-02 | UKALL14- Intens/CNS Proph +Imatinib | 2 | null | 210017263 | UKALL2014 |
| 210032759 | 210009007 | 1.74 | 46 | Curative (C) | null | 2016-09-27 | UKALL14- Intens/CNS Proph +Imatinib | N | N | 210017279 | UKALL2014 |
| 210032760 | 210009008 | 1.6 | 57.7 | Neo-adjuvant (N) | 2016-10-02 | 2016-10-03 | UKALL 14 TRIAL | N | N | 210017279 | UKALL2014 |
| 210032761 | 210009011 | 1.77 | 132 | Curative (C) | 2016-04-26 | 2016-05-03 | UKALL14- Ph 2 Induction | 02 | N | 210017313 | UKALL2014 |
| 210032762 | 210019695 | 1.71 | 84.9 | Neo-adjuvant (N) | 2017-12-27 | 2017-12-27 | UKALL14- Cons Cycle 1 | 02 | N | 210017326 | UKALL2014 |
| 210032763 | 210009016 | 1.77 | 80.8 | Palliative (P) | 2018-12-02 | 2018-12-02 | UKALL14- Cons Cycle 3 | 02 | N | 210017334 | UKALL2014 |
| 210032765 | 210009022 | 1.46 | 73.6 | null | 2017-12-18 | 2018-04-02 | UKALL14- Ph 2 Induction + Imatinib | N | N | 210017387 | UKALL2014 |
| 210032766 | 210019705 | 1.84 | 63.1 | Curative (C) | 2013-08-29 | 2013-12-05 | UKALL14- Maintenance | Y | N | 210017394 | UKALL2014 |